The use of misoprostol for abortion at ≤ 9 weeks' gestation

European Journal of Contraception and Reproductive Health Care

Volumn 2, Issue 3, 1997, Pages 181-185

  Carbonell, J Ll ^a,c   Varela, L ^b   Velazco, A ^b   Fernandez C ^b   Sanchez C ^b  

^a Family Planning Center   (Spain)

^b Hosp Docente Gineco Obstetrico E   (Cuba)

^c Mediterranea Medica Clinic   (Spain)

Author keywords

Misoprostol; Pregnancy termination

Indexed keywords

ABORTIVE AGENT; MISOPROSTOL;

ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG SELF ADMINISTRATION; ECHOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INDUCED ABORTION; INTRAVAGINAL DRUG ADMINISTRATION; METHODOLOGY; PREGNANCY; TIME; UTERUS; UTERUS BLEEDING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADMINISTRATION, INTRAVAGINAL; ADULT; FEMALE; GESTATIONAL AGE; HUMANS; MISOPROSTOL; PREGNANCY; PREGNANCY TRIMESTER, FIRST; SELF ADMINISTRATION; TIME FACTORS; UTERINE HEMORRHAGE; UTERUS;

EID: 0031217996     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.3109/13625189709167474     Document Type: Article

References (20)

1. Ladipo OA. Preventing and managing complications of induced abortion in Third World countries. Int J Gynecol Obstet 1989; 3: 21-8
2. Carbonell JLl, Varela L, Velazco A, et al. The use of misoprostol for termination of early pregnancy. Contraception 1997; 55: 165-8
3. Creinin MD, Darney PD. Methotrexate and misoprostol for early abortion. Contraception 1993; 48: 339-48
4. Creinin MD. Methotrexate and misoprostol versus misoprostol alone for early abortion. A randomized controlled trial. J Am Med Assoc 1995; 272: 1190-5
5. Creinin MD, Vittinghoff E, Keder L, et al. Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy. Contraception 1996; 53: 321-7
6. Creinin MD. Oral methotrexate and vaginal misoprostol for early abortion. Contraception 1996; 54: 15-18
7. Hausknecht RU. Methotrexate and misoprostol to terminate early pregnancy. N Engl J Med 1995; 333: 537-40
8. Schaff E, Eisinger SH, Franks P, et al. Combined methotrexate and misoprostol for early induced abortion. Arch Fam Med 1995; 4: 774-9
9. Wiebe ER. Abortion induced with methotrexate and misoprostol. Can Med Assoc J 1996; 154: 165-70
10. Schaff E, Eisinger SH, Franks P, et al. Methotrexate and misoprostol for early abortion. Fam Med 1996; 28: 196-9
11. Peyron R, Aubeny E, Targosz V, et al. Early termination of pregnancy with mifepristone (RU486) and the orally active prostaglandin misoprostol. N Engl J Med 1993; 328: 1509-13
12. El-Refaey H, Fajasekar D, Abdalla IM, et al. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995; 332: 983-7
13. Bugalho A, Bique C, Almeida L, et al. The effectiveness of intravaginal misoprostol (Cytotec) in inducing abortion after eleven weeks of pregnancy. Stud Fam Plann 1993; 24: 319-23
14. Koopersmith TB, Mishell DR Jr. The use of misoprostol for termination of early pregnancy. Contraception 1996; 53: 237-42
15. Bugalho A, Faúndes A, Jamisse L, et al. Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion. Contraception 1996; 53: 243-6
16. Henshaw RC, Cooper K, El-Refaey H, et al. Medical management of miscarriage: non-surgical uterine evacuation of incomplete and inevitable spontaneous abortion. Br Med J 1993; 306: 894-5
17. Goldstein S. Embryonic ultrasonographic measurements: crown-rump length revisited. Am J Obstet Gynecol 1991; 165: 497-501
18. Winikoff B, Ellertson C, Clark S. Analysis of failure in medical abortion. Contraception 1996; 54: 323-7
19. Echeverria E, Rocha M. Randomized comparative study of induced labor with oxytocin and misoprostol in prolonged pregnancies. Rev Chil Obstet Ginecol 1995; 60: 108-11
20. Wing DA, Paul RH. A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction. Am J Obstet Gynecol 1996; 175: 158-64